Abstract
Perhaps the most significant developments in joint replacement surgery in the past decade have been in the area of multimodal pain management. The hallmark of this program is preemptive pain control with oral anti-inflammatory agents, gabapentin, IV acetaminophen, regional anesthetic blocks that preserve quadriceps function for TKA (adductor canal block) and pericapsular local anesthetics. Over the past two years utilising this type of program over 50% of our joint replacement patients are now returning home the day of surgery.